Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Non Small Cell Lung Cancer Metastatic × lorlatinib × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Sexual Dysfunction, Physiological 1 Recurrence 1 Non Small Cell Lung Cancer Metastatic 1 Neuroblastoma 1 Neoplasm Metastasis 1 Glioma 1 Glioblastoma 1 Ganglioneuroblastoma 1 Eunuchism 1 Erectile Dysfunction 1 Diffuse Intrinsic Pontine Glioma 1 Astrocytoma 1 ALK-positive Non-small Cell Lung Cancer 1 ALK Positive Non-small Cell Lung Cancer 1

Interventions

osimertinib 1 lorlatinib 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06378892 2024-04-23

ALK-PPL

Centro di Riferimento Oncologico - Aviano

Phase 2 Recruiting

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡